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Abstract
Background: Low rates of adherence to artemisinin-based combination therapy (ACT) regimens increase the risk of
treatment failure and may lead to drug resistance, threatening the sustainability of current anti-malarial efforts. We assessed
the impact of text message reminders on adherence to ACT regimens.
Methods: Health workers at hospitals, clinics, pharmacies, and other stationary ACT distributors in Tamale, Ghana provided
flyers advertising free mobile health information to individuals receiving malaria treatment. The messaging system
automatically randomized self-enrolled individuals to the control group or the treatment group with equal probability;
those in the treatment group were further randomly assigned to receive a simple text message reminder or the simple
reminder plus an additional statement about adherence in 12-hour intervals. The main outcome was self-reported
adherence based on follow-up interviews occurring three days after treatment initiation. We estimated the impact of the
messages on treatment completion using logistic regression.
Results: 1140 individuals enrolled in both the study and the text reminder system. Among individuals in the control group,
61.5% took the full course of treatment. The simple text message reminders increased the odds of adherence (adjusted OR
1.45, 95% CI [1.03 to 2.04], p-value 0.028). Receiving an additional message did not result in a significant change in
adherence (adjusted OR 0.77, 95% CI [0.50 to 1.20], p-value 0.252).
Conclusion: The results of this study suggest that a simple text message reminder can increase adherence to antimalarial
treatment and that additional information included in messages does not have a significant impact on completion of ACT
treatment. Further research is needed to develop the most effective text message content and frequency.
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Introduction
Despite massive international efforts over the past decades,
malaria continues to be one of the primary causes of mortality
worldwide. An estimated 655,000 to 1.24 million people died of
malaria in 2010, and more than half of those who died were
children younger than five years [1,2]. Of malaria deaths, 92%
occurred in sub-Saharan Africa (SSA), where Plasmodium (P.)
falciparum, the most virulent form of the malaria parasite, is most
common. Artemisinin-based combination therapies (ACTs) are
recommended by the World Health Organization (WHO) as the
first-line treatment for uncomplicated P. falciparum malaria in all
cases except the first trimester of pregnancy [1]. P. falciparum has
developed resistance to other treatments, leaving ACTs as the only
first-line treatment suitable for use among the general population
[3,4]. Aided by a subsidy through the Affordable Medicines
Facility-malaria (AMFm), ACTs became more widely available
and affordable in seven pilot SSA countries [5]. Widespread access
to ACTs in both the private and the public sectors is crucial for
averting death and disability from malaria [6], but also increases
the likelihood that P. falciparum strains resistant to artemisinin
derivatives will emerge in Africa, as has already occurred in
Southeast Asia [7,8].
The high frequency of non-adherence to ACTs in SSA is a
primary concern for treatment failure and could also lead to drug
resistance, particularly in patients with high parasite burdens [4].
In a systematic review of antimalarial adherence studies, Banek
et al. found that reported adherence to artemether-lumefantrine
(AL) ranged from 38% to 96% and that adherence to artesunate-
amodiaquine (AS+AQ) ranged from 48% to 93% [9]. In two
studies which included both public and private facilities, Cohen
et al. found that 66% of patients adhered to the prescribed dosing
PLOS ONE | www.plosone.org 1 October 2014 | Volume 9 | Issue 10 | e109032of AL in Uganda [10] and Lemma et al. found that 38% of
patients adhered to the treatment regimen for AL in Ethiopia [11].
Mobile technologies are increasingly being incorporated into
the health sector both in developed and developing countries.
Mobile phone ownership in low-income countries increased from
7.9 phones per 100 inhabitants in 2001 to 78.8 phones per 100
inhabitants in 2011, providing a new and relatively inexpensive
platform to reach a large proportion of patients in low-income
countries [12]. While few studies have examined the effects of text
reminders in developing country settings [13,14], two studies
indicate that text reminders improved patient adherence to HIV/
AIDS treatment in Kenya [15,16] and another study indicates that
text reminders improve health worker adherence to treatment
guidelines for pediatric malaria [17]. We conducted a randomized
trial in northern Ghana to assess the impact of mobile phone-
based text message reminders on ACT treatment completion. To
our knowledge, this randomized controlled trial is the first attempt
to evaluate the impact of text reminders to patients on adherence
to malaria treatment [18].
Methods
Design Overview
This randomized trial took place within a one hour driving
radius of Tamale, Ghana, the capital of Northern Region,
between July and November of 2011. and Checklist S1 contain
the trial protocol and CONSORT checklist.
Ethics Statement
The review boards at the Harvard School of Public Health and
the Ghana Health Services provided ethics approval. All
participants provided written informed consent.
Setting and Participants
The site of the study was the urban area of Tamale, Ghana, and
its peri-urban and rural surroundings (see Figure S1 in file S1 for
geographic location). Tamale is the capital of Ghana’s Northern
Region and has a population of 540,000 people [19]. Malaria is
endemic in the area, with 48.3% of children in the Northern
Region testing microscopy-positive for malaria in 2011 [20]. While
Ghana as a whole is rapidly developing, the Northern region lags
behind the rest of the country on literacy and other indicators [19].
The primary ACTs available in Ghana are AL and AS+AQ. AL
regimens generally contain six doses, with the number of pills in
each dose varying between one and four. AS+AQ regimens
contain six tablets taken in three doses. The first dose of both
treatments is taken immediately or with the next meal, and
subsequent doses are supposed to be taken in 12-hour intervals for
AL and in 24-hour intervals for AS+AQ, so that the full treatment
course should be completed within 60 hours of treatment
initiation, regardless of patient age.
Ghana is also one of seven pilot countries in SSA where ACTs
were subsidized through the AMFm, and thus made available at
low prices both in the public and private health sectors beginning
in August 2010. The average price per adult ACT dose in Ghana
fell from 2.74 to 0.94 in public facilities and from 3.42 to 1.13
in private facilities [5]. Ghana’s National Health Insurance
Scheme also fully covers ACTs for insured patients at registered
facilities. The National Health Insurance Authority estimates that
25.5% of individuals in the Northern Region were active members
in 2010 [21]. It is likely that individuals living in and around
Tamale were more likely to be registered than those in more rural
areas.
The target population was defined as all individuals acquiring
ACTs. Data enumerators compiled a complete listing of vendors
distributing ACTs within a 30-minute drive of Tamale. As shown
in Table S1 in file S1, enumerators compiled a list of 217 ACT
vendors within 30 minutes driving time from the center of Tamale.
The most common vendor types were licensed chemical sellers
(177), followed by pharmacies (15), private clinics (7) and public
hospitals (6). Daily Patient and ACT volumes were highest at
private and public facilities as well as pharmacies – the three
categories together accounted for about two thirds of the estimated
total daily volume.
We continuously recruited participants from 11 high-volume
facilities, which primarily included clinics and hospitals, in order to
ensure high enrollment volumes to achieve sufficient power. Data
enumerators made additional recruitment efforts – generally
Figure 1. Study Flow. Notes: 1792 of 3317 screened individuals were eligible to participate in the study. The most common reasons for exclusion
were living more than a 30-minute drive from the ACT vendor and not having a mobile phone, followed by purchasing drugs for somebody who was
not a member of the same household. Of those eligible for study participation, 1140 enrolled with the same mobile phone number that they shared
with data enumerators, of whom 554 were randomized to the control group, 277 to the reminder-only message group, and 309 to the reminder and
additional information message group. A total of 1110 participants reported on their ACT adherence and were included in the main analysis.
doi:10.1371/journal.pone.0109032.g001
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PLOS ONE | www.plosone.org 3 October 2014 | Volume 9 | Issue 10 | e109032restricted to only a few days – at 73 smaller vendors, which were
selected at random from the complete listing of 217 facilities.
Figure S2 in file S1 illustrates the spatial distribution of sampled
vendors in the larger Tamale region.
Vendor Recruitment
Study staff visited all selected vendors a week prior to
participant recruitment to seek vendor consent to participate in
the study and to establish a plan for vendor communication with
data enumerators. Participant registration in the text messaging
system and enrollment in the study then took place in two steps.
First, consenting vendors distributed flyers advertising ‘‘free text
message information about malaria’’ to all individuals acquiring
ACTs. Second, vendors notified data enumerators assigned to
each shop of the ACT acquisition, and data enumerators initiated
study enrollment.
Participant Recruitment
Participant recruitment for the study took place immediately
following acquisition of the malaria treatment and vendor
distribution of the flyer. Data enumerators sitting near shop exits
approached individuals who acquired anti-malarial treatment
when notified of the acquisition by vendors. Data enumerators
invited the individuals to participate in a household survey
focusing on health and informed them that participating in the
household survey would be associated with an interview conducted
in their household at a later date; no further information was
provided regarding the study’s focus on malaria treatment or
adherence in order to avoid influencing participants’ behavior or
reporting.
Study eligibility was restricted to individuals 18 or older, to
individuals purchasing malaria medicine for themselves or
someone in their household, to individuals living within a
Figure 2. Dose completion among adults in the control group. Notes: Figure 2 indicates the proportion of adults in the control group who
reported taking each dose of treatment in the per-dose self-report. Among 239 adults who took AL and reported per-dose adherence, 200 (83.7%)
reported taking the fourth dose, 174 (72.8%) reported taking the fifth dose, and 135 (56.5%) reported taking the sixth dose. Among 70 adults in the
control group taking AS+AQ, 33 (47.9%) reported completing the full three-dose regimen.
doi:10.1371/journal.pone.0109032.g002
Table 2. Effect of text message treatment on self-reported adherence.
Percent completed treatment
Adjusted OR
(95% CI)
Control Group (n=538) 61.5 Reference Group
Message A (n=572) 66.4 1.45**
(1.03–2.04)
Message B (n=304) 64.1 0.77
(0.50–1.20)
Sample size 1110 1110
Notes: Covariates are all those listed in Table 1, including sex and age of the patient, and household characteristics. **p,0.05.
doi:10.1371/journal.pone.0109032.t002
Randomized Trial on Text Reminders for Antimalarial Adherence
PLOS ONE | www.plosone.org 4 October 2014 | Volume 9 | Issue 10 | e109032Table 3. Per-protocol Subgroup Analysis.
Control Reminder text message Long message
Proportion
adhering (%)
Proportion
adhering (%)
Adjusted OR
(95% CI)
Proportion
adhering (%)
Adjusted
OR (95% CI)
Age
Children 71.4 76.9 2.30** 70.5 0.44**
(N) (164) (215) (1.01–5.26) (112) (0.20–0.99)
Adults 57.3 60.7 1.26 60.9 0.96
(N) (373) (352) (0.92–1.72) (189) (0.64–1.42)
Sex
Male 63.1 70.5 1.35 70.7 1.05
(N) (206) (220) (0.86–2.13) (116) (0.4–1.74)
Female 57,6 66.2 2.11*** 60.5 0.58
(N) (238) (278) (1.20–3.75) (147) (0.28–1.18)
HH head education
None 57.9 64.2 2.02** 57.8 0.44**
(N) (195) (218) (1.14–3.56) (109) (0.23–0.82)
Some 60.9 66.8 1.23 69.5 1.45
(N) (197) (205) (0.67–2.24) (105) (0.63–3.36)
High 71.3 72.0 1.38 66.1 0.46
(N) (101) (100) (0.57–3.37) (59) (0.18–1.21)
Wealth Quintile
Poorest 65.7 69.3 1.02 72.0 1.35
(N) (105) (101) (0.37–2.85) (50) (0.43–4.24)
2
nd 61.2 69.9 2.55** 66.0 0.47
(N) (98) (93) (1.09–5.96) (50) (0.18–1.23)
3
rd 58.5 64.1 1.69 65.1 0.91
(N) (118) (131) (0.77–3.69) (41) (0.44–1.89)
4
th 65.5 64.7 1.77** 57.7 0.40***
(N) (110) (133) (1.05–2.98) (78) (0.25–0.66)
Wealthiest 57.6 66.7 1.29 65.8 0.93
(N) (106) (111) (0.63–2.63) (61) (0.27–3.16)
Facility
LCS (N) 58.0 57.1 0.79 62.3 1.51
(138) (147) (0.44–1.40) (76) (0.75–3.04)
Private 61.1 75.0 2.07*** 70.8 0.73***
Clinic (N) (54) (48) (1.47–2.91) (24) (0.60–0.88)
Private 61.5 67.2 2.00*** 59.1 0.38***
hospital (N) (122) (128) (1.54–2.60) (66) (0.29–0.52)
Public 69.7 77.5 1.69 72.7 0.36***
clinic (76) (89) (0.81–3.53) (44) (0.19–0.69)
(N)
Public 65.3 66.7 1.39 63.8 0.73
hospital (118) (126) (0.91–2.13) (44) (0.28–1.85)
(N)
Treatment
AL 0.61 0.64 1.51 0.61 0.67
(N) (305) (320) (0.88–2.59) (174) (0.34–1.33)
AS+AQ 0.625 0.71 2.25** 0.64 0.41***
(N) (144) (163) (1.17–4.30) (79) (0.22–0.78)
Notes: N is the number of people in each subgroup, such as the number of children whose caregivers received the simple reminder message. Covariates are all those
listed in Table 1, including sex and age of the patient, and household and facility type. There were fewer than 30 individuals in the main analysis who received ACTs
from pharmacies, health posts, CHPs zones, or health professionals’ homes. ***p,0.01, **p,0.05.
doi:10.1371/journal.pone.0109032.t003
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mobile number for a personal or shared mobile phone.
Enumerators informed study participants who met the inclusion
criteria about the household interview to take place within the next
few months, and, upon consent, enrolled participants in the study.
After the initial consent, surveyors conducted a short interview to
collect contact information for eligible participants. Both those
who were eligible and those who were ineligible completed a short
exit interview designed to capture basic demographic information.
Individuals who registered in the mobile phone system based on
the flyer but who were not eligible for the study received messages
but were not enrolled in the study.
Participant registration in the text messaging system
Participants who received flyers from vendors and enrolled in
the text-messaging program in response to the flyer used their own
phones to enroll and did not receive any assistance from data
enumerators. Registration in the text messaging system was
possible either by a short ring (‘‘flashing’’) of the number provided
on the flyer or by sending an empty text message to the same
number. While flashing is free for the user, phone service providers
in Ghana require a non-zero balance to initiate any call, and
sending a text message costs between 5 and 10 Ghana pesewas
(US 0?03-US 0?06). Registration in the system was confirmed by
a text-message stating, ‘‘Thanks for registering for Mobile Health
Information.’’ Patients who called or sent a text to the system while
enrolled received an additional message stating, ‘‘You are already
registered. To stop receiving messages, text STOP. Thanks.’’ If the
system received a ‘‘STOP’’ message, it sent a confirmation (‘‘You
will not receive any more messages from Mobile Health’’) and
automatically discontinued sending any further messages.
Message Design
To develop the content of messages, we reviewed the literature
on SMS reminders and attention. We shared a variety of possible
messages with participants of 8 focus groups and 24 individual
interviews with adult male and female participants in rural and
peri-urban Tamale in March 2011. Participants provided feedback
on clarity, appropriateness, and predicted effectiveness of the
various message options. Based on the feedback obtained in
interviews and focus groups as well as in a small pilot study
conducted in Cape Coast in June 2011, the research team opted
for a simple reminder message (message A) and an additional
encouragement component (message B), highlighting the impor-
tance of finishing the drugs when malaria symptoms become weak
or absent – one of the primary obstacles to regimen completion
reported in preliminary field work. The final message treatments
were as follows:
Message A: ‘‘Please take your MALARIA drugs!’’.
Message A+B: ‘‘Please take your MALARIA drugs! Even if
you feel better, you must take all the tablets to kill all the malaria.’’
Randomization of Messages
The text-messaging program was based in the programming
language Python version 2.6 and was built on a Django platform
(the program is open source and can be found at https://github.
com/waveswinger34/pactremind). Participants were sequentially
(in order of their enrollment) assigned to treatment and control,
with every other enrolled subject assigned to either treatment or
control in an alternating manner. The text messaging system then
further randomized participants within the treatment condition to
receive message A or message A+B with equal probability, based
on a pseudo-random number draw.
Message Rollout
All participants in the treatment group received the assigned
reminder messages in 12-hour intervals for three days, for a total of
60 hours, overlapping with the typical treatment protocol for
ACTs. Participants in the control group received no message
during this period. Given that ACT administration is recom-
mended after meals, evening messages were sent at 7pm, while
morning messages were sent at 8am. All participants in the control
and in the treatment groups received a generic malaria prevention
message about bed nets after 120 hours, which ended the text
message activities.
Outcomes and Follow-up
Data enumerators conducted follow-up interviews approximate-
ly 72 hours after participants enrolled in the study. Individuals
who could not be reached for in-person follow-up interviews after
three attempts were contacted by phone for short phone
interviews. All study materials were printed in English, the
standard language used for written communication in Ghana.
Enumerators interacting with subjects during the baseline and
follow-up interviews were not aware of treatment assignment prior
to the interview.
Adherence to antimalarial treatment is generally based on self-
report and observation of pill packets [9,14]. The primary
outcome variable in this study was self-reported completion of
the ACT treatment regimen, with the interviewee reporting
whether the patient completed all of their doses. To allow for some
delays in treatment initiation, all follow-up interviews were
scheduled at least 66 hours after the initial visit; therefore, any
unfinished dose found during follow-up visits could be considered
as evidence of non-adherence. To address concerns regarding
potential recall and social desirability biases associated with
self-reports and to validate the robustness of the outcome measure
[22,23] study staff collected information on two additional
adherence measures.
First, at the beginning of the interview, and before asking
patients any questions regarding the preceding illness episode and
its treatment, interviewers took a complete inventory of all drugs
stored in the households. If participants were willing to show study
Table 4. Self-reported treatment completion and remaining pills or ACT Stock.
Participant reports treatment completion
(N=711)
Participant reports incomplete treatment
(N=399)
Pills found in blister back (%) 6.4 97.9
ACTs found as part of drug inventory (%) 37.1 72.1
Notes: The proportion of participants who reported adherence and non-adherence and who either had pills remaining in an observed packet or had an ACT stock in the
home. Enumerators observed pill packets for 667 (60.1%) participants and drug stocks for 929 (83.7% of) participants.
doi:10.1371/journal.pone.0109032.t004
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available in the household and documented the presence of ACTs.
While this was not a direct measure of adherence, we expected the
drug inventory to be correlated with adherence, and for patients
who did not finish their pills to be more likely to still have ACTs at
their home. After the drug inventory, interviewers asked respon-
dents to report their overall adherence and to complete a detailed
self-report module with the exact quantity of each ACT dose.
Second, at the end of the treatment module, surveyors asked
patients to see the original blister pack; if participants were willing
and able to share the blister pack, data enumerators observed the
number of remaining pills. We compared the main self-report
outcome to both the household drug inventories and to the
observation of the blister packs to assess the strength of the self-
report outcome. We did not incorporate pill packet observation
into the final outcome measure due to potential bias in which
participants shared pill packets.
Statistical Analysis
The study was powered to detect a 10% increase in adherence
with power 0.9, assuming an alpha of 0.05 and a control group
adherence of 60% based on estimated adherence in a similar study
in Uganda [10]. We estimated intent-to-treat (ITT) multiple
logistic regression models to estimate the impacts of receiving
Message A and Message B relative to the control group,
controlling for random patient characteristics that could influence
treatment adherence and clustering standard errors by vendor.
The covariates included were sex of the patient, patient age,
whether the household head was male, educational attainment of
the household head, household wealth quintile, and the type of
vendor where participants sought treatment. The household
wealth index was constructed using principal components analysis
based on household cooking arrangements, water source, sanita-
tion, as well as ownership of mobile phones, and air conditioners.
Household head educational attainment was classified as no
education if the individual had zero years of education, some
education if the individual attended primary or secondary school,
and higher education if the individual attained undergraduate or
other education after secondary school. In addition to the main
analysis, we conducted a pre-specified subgroup analysis by age,
sex, household head education, wealth, and vendor type using
logistic regression. To check the validity of the outcome measure,
we tabulated the proportion of patients reporting treatment
completion or incompletion against observed pills and observed
ACT stock. Finally, we assessed the impact of treatment on still
feeling ill during the follow-up interview using logistic regression
with covariates. All analysis was conducted using the Stata 11
statistical software package [24].
Trial Registration
This trial is registered as trial NCT01722734 at clinicaltrials.-
gov. We regret that we registered the trial late because we were not
aware of the requirement to register randomized trials. There are
no ongoing trials related to this study, and any future trials related
to this study will be registered.
Results
Enrollment
Figure 1 provides an overview of the study. Of 3317 individuals
screened for participation, 1525 were ineligible for study
participation. The most common reason for exclusion was distance
to the facility, with 27% of screened subjects excluded because
they lived further than 15 miles from the city of Tamale. Of those
who were screened, 11% were excluded because they could not
report a mobile phone number at which they could be regularly
reached. An additional 18% of those screened were excluded
because they bought the drugs for somebody who was not part of
their household, because they were under the age of 18, or because
they were not willing to participate in the study.
Data enumerators conducted baseline and follow-up interviews
with all 1792 eligible participants. Of those eligible, 1140 (63%)
enrolled in the SMS system using the same phone number they
shared with enumerators. Out of the 652 participants who did not
register in the SMS system using the phone number they shared
with enumerators, 197 (37%) self-reported successfully enrolling in
the system; however, without a matching phone number, we were
unable to determine their treatment assignment and did not
include them in the analysis. The primary reason subjects reported
not being able to register in the mobile system during the follow-up
interview was a lack of credit (29%); even though enrollment in the
system was designed to be free, ‘‘flashing’’ or texting requires
having credit on the phone. The other main reasons for non-
enrollment were forgetting the phone at home (23%) and lack of
time (14%). Less than ten percent of non-enrollees reported
difficulty with the network or phone coverage as the principal
reason for not enrolling.
Of the 1140 participants enrolled in the text messaging system
using the phone numbers shared with data collectors, 1128
(99.3%) were followed-up in person, 8 (0.7%) were followed up via
phone call, and 4 (0.4%) were lost to follow-up. In addition to the
4 lost to follow-up, a further 26 subjects (2.3%) were excluded from
Table 5. Effect of treatment on still feeling sick.
Proportion completed treatment
%
Adjusted OR
(95% CI)
Control Group (n=538) 29.5 Reference group
Message A (n=577) 30.9 1.06
(0.78–1.45)
Message B (n=303) 30.7 1.02
(0.79–1.30)
Sample size 1110 1110
Notes: Patients reported still feeling sick at the time of the follow-up interview. Logistic regression includes the full set of covariates listed in Table 1, including sex and
age of the patient, household and facility characteristics.
doi:10.1371/journal.pone.0109032.t005
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in a total analysis sample of 1110 participants.
Table S1 in file S1 shows enrollment by vendor type. The
distribution of the sample population in terms of vendors is fairly
similar to the overall patient population of Tamale, with some
overrepresentation of patients from public health facilities and
underrepresentation of patients from pharmacies.
Descriptive Statistics
Table 1 shows baseline characteristics of the population
enrolled in the trial and the populations excluded from the trial.
Individuals were excluded from the trial either due to ineligibility
or because they did not register for the text messaging system using
the phone number that they shared with data enumerators. The
characteristics of the control group and the treatment group are
similar, though there were minor differences in age structure, with
slightly more subjects of age 5–17 years in the treatment group
than in the control group and more subjects of age 18–60 in the
control group than in the treatment group. The characteristics of
individuals who were eligible for the study but did not enroll in the
text message system using the phone number shared with
providers are similar to those of individuals who were included
in the main analysis. Those excluded from the study due to
ineligibility were more likely to be in lower wealth quintiles and
had household heads with lower educational attainment than
those in the main analysis.
While mobile phone ownership was high, with only 11% of
individuals screened not able to share a mobile phone number at
which they could be reached, text messaging on phones was not
widespread. Only 323 (28.3%) of study participants reported
sending any text messages within the last week.
Adherence
Figure 2 summarizes basic dose completion patterns for adult
participants in the control group. Among 239 adults who took AL
and reported per-dose adherence, 92.0% reported completing the
first three doses. Adherence to the prescribed treatment rapidly
declined starting with the fourth dose. Among adults in the control
group, 200 (83.7%) reported taking the fourth dose, 174 (72.8%)
reported taking the fifth dose, and 135 (56.5%) reported taking the
sixth dose. Among 70 adults in the control group taking AS+AQ,
33 (47.9%) reported completing the full, three-dose regimen.
Message Impact on Adherence
Table 2 shows the main results for the impact of text reminders
on self-reported treatment completion. Of 538 participants in the
control group, 61.5% report treatment completion. Of 572
participants in the treatment group, 66.4% report treatment
completion. According to the ITT analysis, being sent Message A
significantly increased the odds of adherence (adjusted OR 1.45,
95% CI [1.03 to 2.04], p-value 0.033). Being in the treatment
group to which Message B was also sent did not result in a
significant change in the odds of adherence relative to the control
group (adjusted OR 0.77, 95% CI [0.50 to 1.20], p-value 0.252).
Pre-specified Subgroup Analysis
Table 3 shows subgroup analysis by age, sex, household head
education, household wealth quintile, type of vendor, and type of
drug. Baseline levels of adherence differed, particularly by age,
household head education, and vendor type. Adherence was
greater among children in the control group (71.4%) than adults in
the control group (57.6%), as well as among patients whose
household heads have higher education (71.3%) than some
education (60.9%) or no education (58.0%). More patients who
attended public clinics adhered (69.7%) than those who attended
public hospitals (65.3%), private clinics (61.5%), private hospitals
(61.1%), or LCSs (58.0%).
Our findings indicate that receiving the simple Message A had a
significant impact among children, women, individuals with
household heads with no education, individuals living in house-
hold in the second lowest wealth quintil, individuals obtaining
antimalarial treatment from private hospitals, and individuals
taking AS+AQ. Receiving Message B significantly increased
adherence among individuals obtaining antimalarial treatment
from pharmacies and significantly reduced adherence among
children, individuals whose household heads had no education,
individuals obtaining antimalarial treatment from private hospi-
tals, and individuals taking AS+AQ.
Reliability of Self-reported Adherence Measures
Study staff collected drug inventories for 929 (83.7%) of 1110
participants included in the analysis. Data enumerators were also
able to inspect 667 (60.1%) blister packets. Table 4 shows that
data enumerators observed remaining pills for 6.4% of subjects
reporting ACT completion and a stock of ACTs for 37.1%, while
data enumerators observed remaining pills for 97.9% of partic-
ipants who did not report completing treatment and a stock of
ACTs for 72.1%.
Message impact on patient health
Table 5 shows the associations between treatment and the
patient’s health status as reported during the follow-up interview.
339 respondents (30.2%) reported that the patient still experienced
malaria or fever symptoms when interviewed. Receiving a text
reminder did not have a significant impact on the odds of
remaining sick during the follow-up interview (adjusted OR 1.06,
95% CI [0.78–1.45], p-value 0.700).
Discussion
The results presented in this paper have two main implications.
First, adherence to ACT treatment regimens is low in Ghana,
which is consistent with other studies of antimalarial treatment
adherence in SSA [9–11]. On average, only 61.0% of patients in
the control group reported completing the full regimen of AL, and
62.5% reported completing the full regiment of AS+AQ. The low
overall rate of adherence poses a threat to patient health and to the
sustainability of current anti-malaria efforts.
Second, the results presented in this paper suggest that receiving
a simple reminder stating, ‘‘Please take your MALARIA drugs!’’
significantly increases adherence to antimalarial treatment. The
additional message stating, ‘‘Even if you feel better, you must take
all the tablets to kill all the malaria’’ did not have a statistically
significant impact on adherence. The finding that our message
with more content was not more effective than our shorter
message is consistent with the results in Pop-Eleches et al. [16].
The power to detect additional message impacts was, however,
limited in our setting; further research is necessary to better
understand the most effective content of text message reminders
for increasing medication adherence.
Third, we find that different message content can play an
important role among subgroups. The simple reminder message
appeared to be particularly effective in increasing treatment
completion among children, women, individuals whose household
heads had no education, individuals in the second lowest wealth
quintile, individuals acquiring ACTs from private hospitals, and
individuals taking AS+AQ. Receiving the additional message
Randomized Trial on Text Reminders for Antimalarial Adherence
PLOS ONE | www.plosone.org 8 October 2014 | Volume 9 | Issue 10 | e109032about taking all of the tablets significantly reduced treatment
completion among children whose parents or caregivers received
the message, individuals whose household heads had no education,
individuals obtaining antimalarial treatment from private hospi-
tals, and individuals taking AS+AQ. Message A was significantly
more effective in increasing treatment completion than Messages
A+B for children whose caregivers received the messages, for
individuals whose household heads had no education, for
individuals acquiring ACTs from private hospitals, and for
individuals taking AS+AQ. These results suggest that it is
important to understand the mechanisms driving the impact of
text message reminders on different subgroups and to carefully
design the content of text message reminders based on target
populations.
Receiving a text message did not have an impact on the odds of
still feeling sick during the follow-up interview. Neither the short
message nor the long message impacted still feeling sick during the
follow-up interview. This is consistent with the magnitude of the
impact of the messages on adherence and the magnitude of the
impact of adherence on still feeling sick. The objective of this
intervention is not only to improve individual symptoms, but to
encourage behaviors beneficial for population health in the long
run – in this case, by decreasing the likelihood that artemisinin-
resistant parasites may survive and be spread due to patients
ending their treatment too early [4].
Strengths and Limitations
One of the main critiques of mobile health programs is that they
can be difficult to scale. Our results indicate 63.6% of eligible
participants self-enrolled in the mobile health program and that
flyers are a feasible method of recruiting participants for a mobile
health intervention. Enrolling participants in the text message
system through a flyer also implies that individuals not able or
unwilling to self-enroll in the mobile information system were
excluded from the study and from benefiting from the interven-
tion. In terms of the study population, the self-selected nature of
patients in the study means that the results presented do not
represent treatment effects for the average (or a representative)
population, but rather represent the potential SMS impact on
adherence among subjects who would self-enroll in a reminder
system.
We also could not match individuals to their treatment unless
the phone number they provided matched a phone number in the
system. The study would have been strengthened by asking
participants if they had multiple phone numbers and through
additional methods of tracking randomization assignment.
One of the limitations of this study, and text message programs
in similar settings more generally, is the importance of mobile
phone literacy. While only 11% of households had to be excluded
from the study because of lack of access to phones, only 28.3% of
participants had sent a text message within the past week. The
effectiveness of the program may have been limited by mobile
phone literacy.
The intervention, by nature of its delivery via personal mobile
phones, is limited in its ability to reach those of lowest
socioeconomic status. Mobile phone ownership among people of
low socioeconomic status may increase as mobile service and
mobile phones become increasingly ubiquitous. There is promis-
ing evidence that the short text message had a greater impact on
adherence among patients whose household heads had no
education, as well as among females and children. There was,
however, no clear trend across wealth quintiles.
It is also worth highlighting that similar interventions may yield
different results in other developing country settings. Compared to
other developing countries, Ghana has made fast progress both
with respect to income and average education levels of its
population; nevertheless, education and literacy levels remain
low among the adult population, particularly in northern Ghana.
Better results seem feasible in settings with higher levels of literacy
and more frequent mobile phone use.
Finally, the study is somewhat limited by its use of self-reported
adherence as a primary outcome measure. Even though all
evidence collected as part of this study suggests that systematic
misreporting is likely limited and balanced across treatment
groups, self-report does present a risk of inaccuracies due to bias
and imperfect memory.
Conclusions
The results of this study suggest that receiving a simple text
message reminder can increase adherence to antimalarial treat-
ment. Further research is needed to develop the most effective text
message reminder content and frequency.
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